(ADMA) ADMA Biologics - Performance 248.9% in 12m
Compare ADMA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
80.04%
#5 in Group
Rel. Strength
99.05%
#77 in Universe
Total Return 12m
248.88%
#3 in Group
Total Return 5y
641.08%
#3 in Group
P/E 27.0
67th Percentile in Group
P/E Forward 29.0
77th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 2.13%
93th Percentile in Group
12m Total Return: ADMA (248.9%) vs XBI (-5.4%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
| LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
| BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ADMA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADMA
| Total Return (including Dividends) | ADMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 19.82% | 5.55% | -0.45% |
| 3 Months | 41.29% | -9.75% | -6.29% |
| 12 Months | 248.88% | -5.39% | 13.04% |
| 5 Years | 641.08% | -13.20% | 111.82% |
| Trend Score (consistency of price movement) | ADMA | XBI | S&P 500 |
| 1 Month | 86.4% | 70% | 47.5% |
| 3 Months | 86.8% | -88.1% | -87.3% |
| 12 Months | 67.2% | -44.4% | 54.3% |
| 5 Years | 81.8% | -53.6% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #50 | 13.5% | 20.4% |
| 3 Month | #8 | 56.6% | 50.8% |
| 12 Month | #3 | 269% | 209% |
| 5 Years | #2 | 754% | 250% |
FAQs
Does ADMA ADMA Biologics outperforms the market?
Yes,
over the last 12 months ADMA made 248.88%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ADMA made 41.29%, while XBI made -9.75%.
Over the last 3 months ADMA made 41.29%, while XBI made -9.75%.
Performance Comparison ADMA vs Indeces and Sectors
ADMA vs. Indices ADMA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.06% | 20.3% | 21.7% | 236% |
| US NASDAQ 100 | QQQ | 1.14% | 17.9% | 21.0% | 234% |
| US Dow Jones Industrial 30 | DIA | 2.60% | 22.7% | 22.5% | 240% |
| German DAX 40 | DAX | 2.42% | 20.0% | 3.62% | 224% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.71% | 23.0% | 25.4% | 244% |
| Hongkong Hang Seng | HSI | 2.46% | 21.3% | 21.2% | 236% |
| India NIFTY 50 | INDA | 4.58% | 14.9% | 21.8% | 246% |
| Brasil Bovespa | EWZ | 3.69% | 17.0% | 16.0% | 256% |
ADMA vs. Sectors ADMA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.91% | 20.4% | 15.7% | 225% |
| Consumer Discretionary | XLY | 2.03% | 20.4% | 20.5% | 234% |
| Consumer Staples | XLP | 4.12% | 20.6% | 17.6% | 238% |
| Energy | XLE | 6.32% | 33.9% | 26.9% | 258% |
| Financial | XLF | 3.17% | 21.8% | 14.8% | 226% |
| Health Care | XLV | 4.76% | 24.5% | 26.9% | 250% |
| Industrial | XLI | 1.74% | 19.5% | 20.7% | 238% |
| Materials | XLB | 3.87% | 23.0% | 29.6% | 253% |
| Real Estate | XLRE | 2.17% | 20.9% | 21.6% | 231% |
| Technology | XLK | 0.50% | 17.4% | 24.7% | 238% |
| Utilities | XLU | 3.34% | 19.7% | 17.3% | 228% |
| Aerospace & Defense | XAR | 1.03% | 12.8% | 7.83% | 221% |
| Biotech | XBI | 2.22% | 14.3% | 37.0% | 254% |
| Homebuilder | XHB | 3.33% | 21.9% | 36.7% | 255% |
| Retail | XRT | 3.30% | 21.0% | 27.7% | 250% |